The case for assessing cannabidiol in epilepsy

The case for medical marijuana in epilepsy

(2014) Edward Maa et al.   EPILEPSIA

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

(2014) Orrin Devinsky et al.   EPILEPSIA

A Revisited Strategy for Antiepileptic Drug Development in Children

(2013) Catherine Chiron et al.   CNS DRUGS

Opportunity gained, opportunity lost: Treating pharmacoresistant epilepsy in children

(2013) Elizabeth J. Donner   EPILEPSIA

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy

(2013) Brenda E. Porter et al.   EPILEPSY & BEHAVIOR

Cannabidiol as a potential treatment for psychosis

(2013) C.D. Schubart et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Does Using Marijuana Increase the Risk for Developing Schizophrenia?

(2013) A. Eden Evins et al.   JOURNAL OF CLINICAL PSYCHIATRY

Slim Evidence for Cannabinoids for Epilepsy

(2013) John W. Miller   Epilepsy Currents

Cannabis use and vulnerability for psychosis in early adolescence-a TRAILS study

(2012) Merel F. H. Griffith-Lendering et al.   ADDICTION

Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: A prospective cohort study

(2012) A. T. Berg et al.   NEUROLOGY

Adolescent bullying, cannabis use and emerging psychotic experiences: a longitudinal general population study

(2012) C. J. Mackie et al.   PSYCHOLOGICAL MEDICINE

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

(2012) F M Leweke et al.   Translational Psychiatry

Cannabis use before age 15 and subsequent executive functioning

(2011) Maria Alice Fontes et al.   BRITISH JOURNAL OF PSYCHIATRY

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

(2011) Mateus M Bergamaschi et al.   NEUROPSYCHOPHARMACOLOGY

Phytocannabinoids as novel therapeutic agents in CNS disorders

(2011) Andrew J. Hill et al.   PHARMACOLOGY & THERAPEUTICS

Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels

(2009) D. Ryan et al.   JOURNAL OF NEUROSCIENCE

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

(2009) Angelo A. Izzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY